,outcome,arm 1,arm 2
0,intervention,induction,noninduction
0,incidence of adverse events,"11.3 %, 25.2 %, 32.5 %, 37.3 %","10.1 %, 19.0 %, 3.2 %, 9.5 %"
0,"incidence of adverse events, cytomegalovirus ( CMV ) infection",17.9 %,5.7 %
